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Serial interactome capture of the human cell
nucleus
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Novel RNA-guided cellular functions are paralleled by an increasing number of RNA-binding
proteins (RBPs). Here we present ‘serial RNA interactome capture’ (serIC), a multiple
purification procedure of ultraviolet-crosslinked poly(A)–RNA–protein complexes that
enables global RBP detection with high specificity. We apply serIC to the nuclei of
proliferating K562 cells to obtain the first human nuclear RNA interactome. The domain
composition of the 382 identified nuclear RBPs markedly differs from previous IC
experiments, including few factors without known RNA-binding domains that are in good
agreement with computationally predicted RNA binding. serIC extends the number of
DNA–RNA-binding proteins (DRBPs), and reveals a network of RBPs involved in p53 signalling
and double-strand break repair. serIC is an effective tool to couple global RBP capture with
additional selection or labelling steps for specific detection of highly purified RBPs.
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A
dvances in RNA research have revolutionized our under-
standing of RNA biology during the last decade1. It is now
apparent that RNA molecules have regulatory and
structural roles in virtually all cellular processes, functions that
are executed via a largely unexplored dimension of RNA–protein
interactions2,3. The vast interconnection between RNAs
and protein factors is reflected in the coordinated cellular
responses to external signals or insults. This includes the
regulation of transcription, where the interplay of RNA and
protein factors controls assembly of the transcriptional machinery
at enhancers and promoters4,5. Accordingly, a growing number
of dual specificity DNA–RNA-binding proteins (DRBPs) have
been identified, although their exact number in the human
genome is still unclear6. Further examples are the regulation of
chromatin structure7, or the DNA damage response (DDR),
where sensing of DNA damage and recruitment of DNA repair
factors to lesions are paralleled by an extensive shift in RNA
metabolism8,9. At the same time, several DNA repair proteins
have the capacity to bind RNA, and an essential RNA component
seems to be part of the DDR10–13.
The underlying protein–RNA interactions within such
functional networks are still mostly deciphered on a gene-by-gene
basis. Novel tools to accurately identify and characterize these
interactions are therefore highly desired. Two landmark studies
introduced the RNA interactome capture technique (IC), which for
the first time enabled identification of in vivo protein–RNA
interactions on a cellular scale14,15. This method uses irradiation of
living cells with ultraviolet light to introduce covalent crosslinks
between proteins and RNA in direct contact, while avoiding
protein–protein crosslinks. After cell lysis, polyadenylated
transcripts are captured by hybridization to oligo(dT)-beads,
washed under denaturing conditions, and crosslinked proteins
are identified by LC-MS/MS. The RNA interactomes presented by
these global studies provided catalogues of RNA–protein networks
in living cells. These networks were more extensive than previously
assumed, comprising an unexpected number of proteins without
classical RNA-binding domains (RBDs) or other features that
allow the prediction of RNA-binding properties14,15. IC was
subsequently applied to mouse embryonic stem cells and yeast, and
consistently identified large numbers of proteins without assigned
functions in RNA biology, collectively referred to as
enigmRBPs16,17.
One limitation of previous global IC profiles is the lack of
subcellular spatial resolution, which is especially relevant if the
biological context of novel protein–RNA interactions is
unknown. To catalogue the RNA–protein network involved in
transcriptional regulation, nuclear RNA processing, chromatin
structure and DNA repair, we thus set out to identify the nuclear
RNA interactome. To enable comprehensive in vivo RBP
detection with maximal specificity, we have developed serial IC
(serIC), a method that includes repeated high-stringency RBP
purifications. serIC can be easily coupled to intermittent
enzymatic treatments or additional selection and modification
steps to obtain highly selected RNA–protein complexes.
When applied to isolated cell nuclei, serIC recovers substantially
fewer proteins without predicted RNA-binding function than
previous single-IC studies, and is thus in better agreement with
computational RNA-binding predictions. With this nuclear RNA
interactome we provide a high confidence list of dual specificity
DNA–RNA binders, including transcription factors and
chromatin components, with minimal background from DNA-
binding proteins. Novel DRBPs extensively link transcription
regulation with RNA processing. We also reveal a dense network
of RNA-binding DNA repair factors involved in the p53 response
and NHEJ, supporting the emerging concept of an RNA-guided
DDR.
Results
serIC yields a highly purified nuclear RNA interactome. We
initially set out to define a nuclear RNA interactome by applying
IC to the nuclear and chromatin compartment of K562 myeloid
leukaemia cells. We chose this cell line, since growth in
suspension culture more easily allows scaling up starting material
for IC by three- to fivefold compared with the two previous
whole-cell studies, to compensate for the reduced material
obtained from the nuclear compartment14,15. We irradiated
B1 109 K562 cells with ultraviolet light to induce protein–RNA
crosslinks, and subsequently extracted whole nuclei or chromatin
via biochemical fractionation18,19. Lysis, binding of poly(A)-RNA
to oligo d(T) magnetic beads and subsequent washes were
performed under denaturing conditions (see Methods;
Fig. 1a)14,15. PAGE and silver staining reveal the specific
recovery of crosslinked proteins (Fig. 1b, left panel). However,
we detect a substantial amount of DNA in IC purifications, even
after this stringent purification step (Fig. 1c). Residual DNA
might be captured via RNA–DNA hybrids during the poly(A)
pull-down, or via crosslinking of dual specificity DNA and RNA-
binding proteins (RBPs). In either case, the presence of DNA in
IC material is of concern, since this may lead to erroneous
annotation of DNA-binding proteins as RNA binders. Elution of
RBP–RNA complexes into low salt buffer enables subsequent
enzymatic treatments of IC samples, which can be followed by a
second round of oligo d(T)-capture and stringent washes prior to
LC-MS/MS detection (Fig. 1a). We refer to this approach as
serIC, and use it in conjunction with an intermittent turbo
DNAse treatment to eliminate detectable DNA from purified
poly(A)-RNA–protein complexes (Fig. 1c). At the same time,
polyadenylated RNA is efficiently recovered during the serIC
protocol (Supplementary Fig. 1a). Silver staining of isolated
proteins reveals that a substantial amount of non-crosslinked
background proteins is eliminated from non-crosslinked controls
in serIC versus IC samples (Fig. 1b, right panel). Importantly,
there are distinct changes in the recovered protein pattern in
ultraviolet-crosslinked samples after serIC, indicating the removal
of distinct contaminating proteins (Fig. 1b).
We finally subjected isolated proteins to LC-MS/MS. Proteins
were identified using MaxQuant at an FDR of 0.01
(Supplementary Table 1)20. Gene ontology (GO) analysis of the
identified proteins reveals a very high enrichment for the term
‘RNA binding’ (corrected P value 9.5 10 217), confirming the
specificity of the method (Supplementary Fig. 1b). Most identified
proteins are associated to the GO term ‘nucleus’, reflecting the
nature of the starting material (Supplementary Fig. 1c). At the
same time, the number of proteins associated to the term
‘cytoplasm’ alone is strongly reduced compared with the previous
IC studies from whole cells. As expected, proteins from
chromatin purifications are largely recovered in serIC from
whole nuclei (Supplementary Fig. 1d). In total, we identify 382
proteins by serIC in K562 nuclei and chromatin samples. This
corresponds to about half the number identified in each of the
global IC studies14–17, in line with the restriction to the nuclear
compartment. For further analysis, we pooled the 382 RBPs and
collectively refer to them as the nuclear RNA interactome.
serIC recovers few unexpected RBPs. To further assess the
structural features of the nuclear RNA interactome obtained by
serIC, we grouped the identified proteins according to the occur-
rence of classical or non-classical RBDs as previously descri-
bed15,17. We observe a pronounced shift in protein composition of
the recovered RNA interactome (Fig. 1d). Forty-eight per cent of
all proteins identified by serIC in K562 nuclei harbour a classical
RBD, compared with only 26% in previous IC studies14,15. At the
ARTICLE NATURE COMMUNICATIONS | DOI: 10.1038/ncomms11212
2 NATURE COMMUNICATIONS | 7:11212 | DOI: 10.1038/ncomms11212 | www.nature.com/naturecommunications
same time, the proportion of proteins without known RBD
(no-RBD) is reduced by 450%. These differences remain if only
annotated nuclear proteins are considered (Fig. 1e–h). Most
nuclear proteins with classic RBDs that were previously identified
in HEK293 and HeLa cells by IC are also detected by serIC
(Fig. 1e)14,15. However, only about 42% and 18% of the previously
identified candidates with non-classical or no RBDs, respectively,
are detected after the serial purification (Fig. 1f,g).
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Figure 1 | serIC recovers highly purified nuclear RBPs. (a) Comparison of the IC and serIC methods. Irradiation of living cells with ultraviolet (UV) light at
254 nm induces covalent crosslinks between proteins and nucleic acids. After cell lysis, RBP–poly(A)-RNA complexes are captured by hybridization to
oligo(dT) magnetic beads and washed under denaturing conditions. In IC, purified material is eluted and proteins are identified by LC–MS/MS (top). In
serIC, eluted material is enzymatically treated to remove contaminating DNA. Free RBP–poly(A)-RNA complexes are diluted in the presence of high salt
and detergent to disrupt residual non-crosslinked interactions, recaptured by hybridization to oligo(dT) beads and analysed by LC–MS/MS. (b) SDS–PAGE
of proteins crosslinked to poly(A)-RNA. Nuclei from irradiated K562 cells were isolated and subjected to the serIC procedure. Protein–RNA complexes
obtained after the first or second round of purification (first elution and second elution) were digested with RNAseA/T1, separated on a polyacrylamide-
gradient gel, and visualized by silver staining. No UV-crosslinking was performed in controls (No Cl). Asterisks indicate RNase A/T1. (c) Elimination of
DNAse contamination. qPCR measurement of eluate from the first and second round of purification was performed without reverse transcription to detect
residual DNA. Levels of 45S rDNA and LINE 1.3 retrotransposon DNA in the first and second eluate are shown relative to GAPDH mRNA in the second
eluate. Error bars show s.d. from two independent experiments. (d) Domain composition of the nuclear RNA interactome. Proteins identified by LC–MS/MS
in serIC preparations from K562 nuclei, and in previous IC from HeLa15 and HEK293 (ref. 14) were grouped by the presence or absence of classical or non-
classical RBDs as indicated. (e–g) serIC recovery of proteins with the GO association ‘nucleus’ that were previously identified by IC in HeLa15 or HEK293
(ref. 14). Proteins containing classical (e), non-classical (f), or no RBDs (g) were compared separately.
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The disproportionate reduction of proteins lacking known
RBDs in serIC experiments prompted us to compare the overall
efficiency of the serIC purification strategy with previous IC data.
Despite the constraint to the nuclear compartment, the total
number of MS/MS peptide identifications is higher in serIC
compared with the HeLa RNA interactome data15, demonstrating
high purification efficiency and sensitivity of the experiment
(Fig. 2a). Furthermore, fold enrichments of classic and
non-classic RBDs are higher in serIC compared with the IC
data from HEK293 cells, indicative of reduced non-specific
background in serIC controls (Supplementary Fig. 2a)14.
We next asked whether the altered domain composition of the
nuclear RNA interactome reflects differences in protein
abundance between cell lines or between nuclear and cytoplasmic
protein content. We therefore subjected K562 nuclear and
cytoplasmic fractions to LC-MS/MS and identified 3,620
cytoplasmic and 2,225 nuclear proteins. For further comparisons,
we restricted previous IC-derived proteins to members of this
K562 proteome, and refer to them as candidate RBPs.
Comparison of the K562 nuclear versus cytoplasmic proteome
reveals a similar number of RBD-containing proteins in both
compartments, while the number of no-RBD proteins is higher in
the cytoplasm (Supplementary Fig. 3). This difference is
directly reflected in previous IC data, where more no-RBD
proteins are found among cytoplasmic compared with nuclear
candidate RBPs (Fig. 2b). The observed shift in domain
composition between serIC and IC RNA interactomes persists
if only nuclear candidate RBPs are included in the comparison
(Fig. 2b). For each class of proteins, we further subdivided the
IC-only nuclear candidates into a population with similar median
abundance as the RBPs detected by serIC and a population with
reduced abundance in K562 nuclei (Fig. 2c). The same shift in
domain composition between serIC and IC-derived RNA
interactomes is observed when only highly abundant nuclear
candidate RBPs are considered (Fig. 2b).
The majority of nuclear IC-only proteins with classic RBDs
is lowly abundant in K562 nuclei (Fig. 2d). Among the highly
abundant IC-only proteins with non-classic RBDs are 42
ribosomal proteins, indicating reduced crosslinking of poly(A)-
RNA to newly assembled ribosomal subunits in the nucleus. Most
other non-classic IC-only candidates are also lowly abundant in
K562 nuclei. Conversely, the vast majority of nuclear IC-only
no-RBD candidates are found in the highly abundant group.
At the same time, both IC-only and serIC no-RBD candidates are
scattered across the full range of log2 fold enrichment values in
the IC data (Supplementary Fig. 2b–g)14, suggesting that a more
stringent fold-change cutoff does not improve the overlap
between both methods.
Collectively, these data suggest that serIC efficiently detects
RBPs on a global scale. The reduced number of identified no-RBD
proteins does not appear to result from diminished purification
efficiency, MS sensitivity or protein abundance, but is reminiscent
of the observed reduction of unspecific interactions in serIC
compared with single-IC purifications (compare Fig. 1b left and
right panels).
serIC recovers bona fide RBPs with high efficiency. We next
wanted to investigate how efficiently serIC can recover novel
bona fide RNA binders. To test this, we used a computational
RNA-binding prediction performed by Baltz et al.14 for the
unannotated candidate no-RBD proteins identified by IC in
HEK293. Here a multiple association network integration
algorithm was applied to predict gene functions from Gene
Ontology associations, domain composition, structural similarity,
co-expression and protein–protein interaction data14,21. We
grouped 105 highly abundant candidate no-RBD RBPs from
Baltz et al.14 that are highly abundant in the K562 nuclear
proteome according to the precision level at which RNA binding
is predicted by the network integration algorithm. The precision
of the RNA-binding prediction is defined as the proportion of
genes that are correctly classified as having a given function, here
RNA binding, estimated from applying the algorithm to a
reference set of genes with known function22. Around 18% of the
IC-derived nuclear candidate RBPs for which RNA binding could
not be predicted with a precision above 0% are detected by serIC,
confirming that the RNA interactome comprises some proteins
that cannot be identified in silicio as RNA binders (Fig. 3a).
Thirty-one and 61% of the nuclear no-RBD candidates with
an RNA-binding prediction precision above 20% or 50%,
respecitively, are recovered by serIC, highlighting the predictive
power of the network integration algorithm used by Baltz et al.14,
and confirming the sensitivity and accuracy of the serIC
approach. Conversely, the fact that serIC is in better agreement
with the computational prediction than single-IC highlights the
improved specificity of RBP identification.
To further investigate whether no-RBD proteins identified by
serIC are more likely to represent valid RBPs, and to gain
further insight into the mechanisms of non-canonical protein–
RNA interactions, we compared known structural features of
RBPs between serIC and highly abundant IC-only no-RBD
candidates. Unstructured and low complexity amino-acid
sequences have been suggested to play an important role for
mediating non-canonical protein–RNA interactions15,23.
Accordingly, the proportion of amino acids within disordered
regions is significantly higher in no-RBD proteins detected by
serIC compared with IC-only candidates (P¼ 1.4 10 4,
Kolmogorov–Smirnov test), or to the K562 nuclear proteome
(Pr10 4, Fig. 3b). Conversely, the distribution of disordered
regions in IC-only proteins is statistically indistinguishable from
the K562 nuclear proteome (P¼ 0.26). Further corroborating this
finding, no-RBD proteins detected by serIC display a significantly
reduced amino-acid complexity compared with the K562 nuclear
proteome (P¼ 0.006), while complexity in IC-only candidates is
indistinguishable from the background (P¼ 0.1, Fig. 3c).
We furthermore assessed the functional properties of serIC
versus IC-only no-RBD proteins. Figure 3d shows the
most significant non-redundant GO terms for both groups.
serIC-derived no-RBD proteins are highly associated with
RNA-related biological processes. In contrast, IC-only candidates
are enriched for RNA-unrelated processes like unfolded protein
binding and DNA metabolism.
Several conserved protein domains show increased occurrences
among serIC-derived no-RBD proteins, such as the Brix domain,
which is found in proteins involved in ribosome biogenesis
(Supplementary Fig. 4). Despite complete elimination of DNA
contamination, the DNA-binding AKAP95 zinc finger and the
conserved globular H15 domain from linker histones H1 are
enriched among serIC no-RBD RBPs. At the same time, only the
TCP-1/cpn60 chaperonin domain shows increased occurrence
among abundant IC-only no-RBD candidates.. Collectively, the
above analyses provide evidence for the capacity of the serIC
approach to identify bona fide RBPs.
serIC identifies dual specificity DNA–RNA binders. The group
of dual specificity DRBPs is of particular interest, since rigorous
elimination of DNA during the serIC procedure is expected to
eliminate erroneous recovery of DNA-binding proteins. This is
reflected by the elimination of 38 annotated DNA-binding
proteins in serIC compared with the previous IC data. DRBPs
are involved in various processes including the control of
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transcription, splicing and translation, DNA repair, cellular
responses to stress and apoptosis. The extent of DRBPs in human
is, however, still debated6.
Overall, we identify 80 annotated DNA-binding proteins in the
nuclear RNA interactome (Fig. 4). Forty-three of these
contain classical RNA-binding domains. For another 20, direct
RNA-binding has been demonstrated experimentally at the
respective individual protein level. For 17 proteins, direct RNA
binding has not previously been shown or has only been
suggested by previous IC experiments where co-purification via
DNA could not be excluded14,15. Ten of these novel DRBPs are
transcription factors, seven of which have functions in RNA
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Figure 2 | Altered domain composition of the serIC RNA interactome. (a) The combined number of individual LC–MS/MS peptide identifications in all
serIC replicates and in all IC replicates from HeLa15. Indicated are peptides from proteins with classic, non-classic or no RBD. Only peptides from proteins
that are enriched over the control are shown for each experiment. (b) Domain composition of the nuclear RNA interactome. Proteins identified by IC in
HeLa15 and HEK293 (ref. 14) were filtered for expression in K562 nuclei or cytoplasm. All nuclear, only highly abundant nuclear, and cytoplasmic IC-derived
candidates are included in the comparison, respectively. (c) K562 nuclear abundance of the RBPs detected by serIC or in IC only, as measured by LC–MS/
MS14,15. IC-only candidates are subdivided into proteins with similar abundance as serIC-derived RBPs from the same class, and proteins with reduced
abundance. (d) Distribution of lowly or highly abundant candidate RBPs. Highly abundant IC-only candidates mostly lack RNA-binding domains.
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splicing or processing at the same time (Table 1). Three of these
TF/processing factors are also involved in the DDR. We identify
BCLAF and THRAP3, components of the SNARP complex,
which binds to CyclinD1 messenger RNA and regulates its
stability, but also couples the DDR to alternative splicing24. Two
other SNARP components, PNN and SNW1, are also identified
by serIC. The transcriptional repressor MYBBP1A is released
from nucleoli to translocate to the cytoplasm and promote
p53 acetylation when ribosomal RNA (rRNA) synthesis is
inhibited. Due to the lack of an RBD it has been suggested that
MYBBP1A is indirectly tethered to nucleolar rRNA25. Our data
suggest that this regulation could be direct.
Several additional DRBPs couple transcription with RNA
splicing. PHF5A binds to the CX43 promoter and stimulates its
activation by oestrogen receptor alpha26. PHF5A is also part
of the splicing factor 3b protein complex and has been suggested
to bridge splicing factors and DNA helicases27. The AKAP95
domain containing ZNF326 can bind DNA to activate
transcription, but is also part of the DBIRD complex that
couples elongation by Pol II with alternative splicing28.
Two more DRBPs contain AKAP95 zinc fingers. AKAP8 binds
the RII alpha subunit of PKA and regulates chromosome
condensation29. An association of AKAP8 with the RNA
helicase DDX5 has furthermore been observed at the nuclear
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Figure 3 | Good agreement between serIC and computational RBP prediction. (a) All nuclear no-RBD candidate RBPs detected by IC in HEK293, grouped
by the precision of computational RNA-binding prediction14. Highlighted in blue are the proportion and number of proteins that are also identified as RBP by
serIC. (b) Proportion of residues in disordered regions in all K562 nuclear proteins (blue), serIC-derived no-RBD proteins (red) and abundant IC-only
nuclear no-RBD candidates (green). (c) Proportion of residues in low complexity regions with colour code as in b. Asterisks in b and c indicate P values
o10 3 ando10 2, respectively. (d) GO-enrichment analysis of serIC-derived and IC-only nuclear no-RBD proteins. Shown are the most significantly
enriched non-redundant ‘Biological Process’ and ‘Molecular Function’ GO terms compared with the human genome.
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Figure 4 | Novel DRBPs connect transcription regulation to the DDR. All
annotated DNA-binding proteins identified in the nuclear RNA interactome.
Proteins without classic RBDs were interrogated for previous direct
evidence for RNA binding.
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matrix30. The paralog AKAP8L lacks the protein kinase A
binding domain, but interacts with RNA helicase A31. RNA
helicase interactions of both proteins may thus be related to their
RNA-binding capacity.
We identify two kinases among the novel DRBPs. YLPM1
binds to the core promoter of TERT to control its downregulation
in differentiating embryonic stem cells. YLPM1 has also been
suggested to function together with PP1 as a modular nucleoside
kinase, and to interact with the RBPs SAM68, NF110/45 and
hnRNP-G in a nucleic acid-dependent manner, functions that are
consistent with a direct RNA-binding capacity32. Another
DNA–RNA binding kinase in the nuclear RNA interactome is
PRKDC in the DNA-activated protein kinase (DNA-PK), the core
regulator of DNA double-strand break repair by NHEJ11.
Finally, we find all four ubiquitous replication-dependent
linker histones H1.2 to H1.5 but no core histones in the
nuclear RNA interactome, suggesting an RNA-binding capacity
of histone H1.
serIC expands the network of RNA-binding DDR components.
The novel DRBPs identified by serIC support recent evidence
for widespread crosstalk between RNA metabolism and the
DDR33–37. In line with these findings, 22 genes with GO
annotations related to the DDR are part of the nuclear RNA
interactome, including several novel RBPs (Supplementary
Table 1). To obtain an overview of the functional relationship
between RNA-binding components of the DDR, we applied a
multiple association network integration algorithm that
uses information from protein–protein interactions; pathways;
co-expression; co-localization; and shared protein domains to
visualize interactions between the 22 query genes and their
interacting proteins21. The resulting network is highly enriched
for components of the DNA double-strand repair and the
signalling cascades in response to DNA damage (Fig. 5). Two
interacting factors, NSUN2 and MATR3, are also components of
the nuclear RNA interactome. For 15 of the 24 identified RBPs in
the network, previous evidence for RNA binding is available from
direct assays on the individual protein level (green circles), while
six additional factors have been suggested by IC (grey circles)14,15.
We identify 9 direct binding partners of p53 in the nuclear
RNA interactome, including USP10, which deubiquitinates and
activates p53 in response to DNA damage, and Sumo1, which can
itself become covalently coupled to p53 to regulate its activity and
subcellular localization (Supplementary Fig. 5)38–40. Several other
members of the nuclear RNA interactome control p53 expression.
CCAR2 is activated by ATM and ATR kinases to increase p53
transcription, and also regulates DNA repair at heterochromatic
lesions41. Also AATF, which is stabilized upon phosphorylation
by ATM, induces transcription of p53 and p53 target genes42.
RBM38 in turn enhances translation of p53 and the cyclin-
dependent kinase inhibitor p21 (refs 43,44).
The most densely connected subnetwork of RNA interactome
components is the NHEJ branch of the double-stranded DNA
break repair pathway. Highlighted in Fig. 5 are factors that
promote or are directly involved in NHEJ.
MDC1, a key component of the DDR, which we identify here
for the first time as RBP, is recruited to phosphorylated yH2AX at
DNA lesions, where it sustains and amplifies signalling by the
ATM kinase together with TP53BP and provides a scaffold for the
assembly of DNA damage foci45. MDC1 also directly interacts
with the DNA-activated protein kinase (DNA-Pk), the core
regulator of NHEJ and V(D)J recombination, and regulates its
auto-phosphorylation in response to DNA damage46. It has been
shown that recruitment of MDC1 to yH2AX foci is specifically
disrupted on RNAse treatment, which is in agreement with an
RNA-binding capacity36. We also identify RIF1, the main effector
of TP53BP-mediated double-strand break repair pathway choice,
as a novel RBP. RIF1 antagonizes BRCA1 and limits the recession
of damaged DNA ends to prevent homology-directed repair
(HDR) and directs the response towards NHEJ during G1
phase47–50. All components of DNA-PK, including the catalytic
subunit PRKDC are also identified as part of the nuclear RNA
interactome. Finally, Sumo1 functions in its conjugate form
during classic NHEJ and as a free protein in Alt-NHEJ and HR51.
We have validated the RNA-binding of four of these novel
factors, THRAP3, BCLAF1, MDC1 and RIF1 (Supplementary
Fig. 6). In addition to these novel factors, we recover known RBPs
with functions in NHEJ. Taken together, serIC is effective in
recovering a dense network of RNA-binding repair factors,
suggesting tight cooperation of RNA and protein factors during
the DDR.
Discussion
Here we introduce serIC for global in vivo RBP identification
with high specificity. We apply serIC to human cell nuclei to
obtain global poly(A)-RNA–protein interactions with subcellular
Table 1 | Functional classification of novel DRBPs identified in serIC.
Protein TF RNA processing Splicing DDR Enzyme
THRAP3    
BCLAF1    
ZNF326   
PHF5A   
MYBBP1A   
BDP1  
AATF  
YLPM1  
CEBPZ 
KDM5A  
PRKDC  
AKAP8
AKAP8L Putative
HISTH1B
HISTH1C
HISTH1D
HISTH1E
DDR, DNA damage response; DRBP, DNA–RNA-binding protein; serIC, serial RNA interactome capture; TF, transcription factor.
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resolution. The resulting nuclear RNA interactome includes novel
RBPs that link transcription, RNA processing, chromatin
regulation and DNA repair, and will serve as a stepping-stone
for further investigation of the underlying molecular mechanisms
using gene-centered methods.
We observe a shift in domain composition of the nuclear
RNA interactome compared with previous RBP catalogues
derived by IC. The most substantial reduction is observed for
previous candidate RBPs without known RBDs, despite high
abundance of individual candidates in K562 nuclei, while
observing no differences in purification efficiency or detection
sensitivity of serIC compared with IC experiments14,15. Here one
should consider that all purifications are performed under
denaturing conditions so that detection of an RBP–poly(A)-
RNA complex should solely depend on the in vivo crosslinking
event, while the proportions of different RBP classes are not
expected to change during more stringent washes. Conversely,
more stringent purification procedures are expected to
preferentially reduce the contribution from non-crosslinked
non-specific protein interactions. In line with this, we observe
non-crosslinked background proteins in non-irradiated
controls after a single round of purification, which are
eliminated after the second purification step of serIC.
The enrichment of unfolded-protein binding chaperones in
IC samples suggests that specific non-crosslinked interactions
can be induced when captured RNA molecules are coupled
to unfolded proteins in crosslinked samples, leading to
false-positive RBP identification when comparing with non-
crosslinked controls.
The distinct biological and structural features of the nuclear
RNA interactome provide additional evidence for the high purity
of RBP catalogues derived by serIC. No-RBD proteins detected by
serIC are enriched for known features of classic RBPs compared
with IC-only candidates, including a higher proportion of
amino acids in disordered and low complexity regions15,52. At
the same time, serIC-derived No-RBD proteins are enriched for
RNA-related functions, while IC-only proteins are enriched for
terms related to unfolded protein recognition, protein transport
and DNA metabolism. Altogether, these results support the
substantially increased specificity of serIC.
RIF1
TP53BP1
TP53
MATR3
NPM1
SNW1 
DDX39B NSUN2
AATF
RBM38
USP10
ZNF385A
RPS3
CTCF
BCLAF1
ZMYM2 MRE11A
SUMO1
H2AFX
SFPQ
NONO
BARD1BRCA1
SIRT1
CCAR2
DDX5
ATM
TNKSLIG4
NHEJ1
XRCC4
XRCC6
XRCC5
TDP1
DNTT
PRKDC
CDC5L
MDC1
DCLRE1C
RBM14
Pathway
NHEJ Detected in IC Physical interaction
Previous direct evidenceNuclear Interactome
Figure 5 | Network of DDR proteins in the nuclear RNA interactome. Nuclear RNA interactome proteins with GO annotations related to the DDR were
used as query to construct a functional interaction network. First, neighbours were identified using the association data from protein and genetic
interactions, pathways, co-expression, co-localization and protein domain similarity. Proteins were grouped based on physical and pathway interactions.
Indicated are proteins involved in the NHEJ pathway and proteins with previous evidence for RNA binding.
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Coupling of serIC to intermittent enzymatic treatment is
effective for the elimination of contaminating DNA, as evidenced
by the removal of 38 DNA-binding proteins compared with IC.
Elution of intact RBP–poly(A)-RNA complexes into low-salt
conditions after each round of purification enables coupling of
serIC to any additional isolation- or modification step, such as
differential centrifugation, enzymatic treatment, labelling or
affinity purifications. As long as these intermittent treatments
leave RNA–polypeptide complexes intact, additional rounds of
oligod(T)-capture can be performed.
Having ensured elimination of DNA from serIC samples,
recovered DNA-binding proteins are likely to have dual
DNA–RNA-binding specificities. Several modes of action have
been proposed for DRBPs. DRBPs can bind DNA and RNA
independently to execute multiple related or unrelated functions6.
RNA and DNA interactions can also occur simultaneously,
competitively or sequentially within the same biological process6.
DRBPs detected by serIC extensively couple transcription factor
activity with roles in RNA processing, which potentiates the
capacity for gene expression regulation. This is exemplified by
MYBBP1A, which interacts with the RNA Pol I complex to
repress the transcription of rRNA genes, and at the same time
interacts with the ribosome biogenesis machinery53. By ensuring
efficient pre-rRNA processing MYBBP1 thus coordinates
transcription and maturation of ribosomes. Our data suggest
that MYBBP1 exerts this function via direct contact with its target
gene product. Another interesting observation is the recovery of
all replication dependent variants of Histone H1 by serIC. An
RNA component has been shown to be involved in
heterochromatin formation by HP1a54,55. At the same time, the
chromodomain of HP1a cannot interact with native chromatin
on its own, but is dependent on dynamic interactions with
histone H1 to be functional56,57. It is tempting to speculate that
the RNA-binding capacity of H1 takes part in this interplay.
A notable feature of the nuclear RNA interactome is the
extended network of RNA binding DDR components. The
identification of multiple regulators and effectors of p53 signalling
and the recovery of the NHEJ module by serIC is in line with the
emergent role of RNA biology in the DDR33–37. This interplay
occurs at multiple levels: An extensive crosstalk has been observed
between the DDR and posttranscriptional regulation of RNA
splicing and stability, exemplified by the presence of BCLAF1 in
the nuclear RNA interactome, which interacts with phosphorylated
BRCA1 to connect the DDR with splicing regulation58. Recent
evidence further suggests that ncRNAs are directly involved in the
DNA repair process: The recruitment of MDC1 to DNA damage
foci is RNAse sensitive and dependent on the local production of
small RNAs that are generated in a Drosha and Dicer dependent
manner13. The identification of MDC1 as RBP might provide a
molecular basis for this observation. Since serIC recovers RBPs in
complex with polyadenylated transcripts, it is tempting to
speculate that components of the DDR can interact with such
precursors. This would be in line with the observation that DDR
proteins bind to Drosha and can control small RNA
production12,37,59. Alternatively, long ncRNAs that are induced
on DNA damage may provide a scaffold for the assembly of DDR
proteins at DNA lesions, or act as decoys to sequester or
dynamically regulate DDR factors during the multistep repair
process60–62. The fact that we identify 10 RBPs that act sequentially
and closely coordinated during NHEJ argues for such a scenario.
Protein centered methods such as CLIP will help to identify
interacting RNAs of individual DDR proteins and dissect the
underlying molecular events.
Taken together, the first human nuclear RNA interactome
presented here provides a resource for the future investigation of
RNA-guided nuclear processes. In addition to the improved
specificity provided by the serIC method, continuous refinement
of experimental approaches and increasing MS sensitivity
will further improve the ability to detect bona fide RBPs
in vivo. At the same time, novel tools to globally recover
non-polyadenylated RNA–protein complexes are needed to
complete our picture of the RNA interactome. Accordingly,
some aspects of the first RNA interactomes may have to be
reassessed as we have certainly not yet unraveled the full extent of
RBPs in the human genome.
Methods
Cell culture and nuclei isolation. K562 (ATTC) cells were grown in suspension
culture at 75 r.p.m. in RPMI1640 medium supplemented with 10% fetal calf serum
and antibiotics, and maintained at 37 C and 5% CO2. For one replicate serIC
experiment, 4 500ml suspension culture were amplified to a density of 1 106
cells per ml and collected by centrifugation at 200g and 4 C. Cells were combined,
washed with cold PBS, split in half and irradiated in a stratalinker with 0.4 J cm 2
UVC light (256 nm) or used as non-crosslinked control. Cells were recollected by
centrifugation and resuspended in NP-40 lysis buffer (10mM Tris pH 7.4; 150mM
NaCl; 0.15% NP-40; 1mM DTT; complete protease inhibitors (Roche); 1/2,000
SUPERaseIn RNase Inhibitor (Thermo Fisher)). After 5-min incubation on ice,
cells were gently layered over a cold sucrose cushion (10mM Tris pH 7.4; 150mM
NaCl; 24% sucrose; 1mM DTT) and centrifuged for 10min at 1,000g. Nuclei
were resuspended in IC lysis buffer (20mM Tris pH 7.4; 500ml LiCl; 1% LiDs;
5mM EDTA; 5mM DTT) and DNA was sheared by passing through a 20 1/2G
needle.
For chromatin isolation, nuclei were instead resuspended in Glycerol buffer
(20mM Tris pH 7.4; 75mM NaCl; 0.5mM EDTA; 50% Glycerol; 1mM DTT),
mixed with Urea buffer (10mM Tris pH 7.4; 7.5mM MgCl2; 0.2mM EDTA; 0.3M
NaCl; 1M Urea; 1% NP-40; 1mM DTT) and centrifuged for 3min at 3,500g. The
chromatin pellet was rinsed in cold PBS, snap frozen in liquid nitrogen,
resuspended in chromatin lysis buffer A (20mM Tris pH 7.4; 50mM LiCl; 0.5%
NP-40; 0.5% DOC; 0.1% SDS; 10mM CaCl2; 10mM MgCl2; 5mM DTT; complete
protease inhibitors (Roche)) and crushed by passage through a 10-ml syringe and
20 1/2G needle. After adding chromatin lysis buffer B (20mM Tris pH 7.4;
600ml LiCl; 1.2% LiDs; 6mM EDTA; 5mM DTT), the sample was filtered through
a 100-mm cell strainer.
Serial RNA interactome capture. First purification. The first part of the serIC
purification was done largely as described by Castello et al.15. Eight ml oligo(dT)
dynabeads (NEB) were equilibrated with IC lysis buffer (20mM Tris pH 7.4; 500ml
LiCl; 1% LiDs; 5mM EDTA; 5mM DTT), and 2ml were added to each tube with
crosslinked or uncrosslinked lysate (B100ml crosslinked or non-crosslinked lysate
from one biological replicate were each distributed into two 50-ml falcons).
Samples rotated for 1 h at room temperature (RT) or overnight at 4 C. Beads were
collected on a magnet until the lysate was clear (30min–1 h). We stored the
supernatant at 4 C for repeated purification, resuspended the beads in IC lysis
buffer, rotated them for 5min, and collected the beads with a magnet for 10min.
Beads were then washed twice in wash buffer 1 (20mM pH 7.4 Tris HCl; 500mM
LiCl; 0.1% LiDS (wt/v); 0.1% NP-40; 1mM EDTA; 5mM DTT); twice in wash
buffer 2 (20mM pH 7.4 Tris HCl; 500mM LiCl; 0.1% NP-40; 1mM EDTA; 5mM
DTT); and twice in wash buffer 3 (20mM pH 7.4 Tris HCl; 200mM LiCl; 0.1%
NP-40; 1mM EDTA; 5mM DTT). Finally, beads were collected in wash buffer 3
and transferred to a 1.5-ml eppendorf protein LoBind tube. RNA–protein
complexes were incubated for 3min at 55 C in 1ml elution buffer (20mM pH 7.4
Tris HCl; 1mM EDTA). Eluates were snap frozen and stored at  80 C. This
purification scheme was repeated twice with the lysate supernatant from above,
yielding a total of 3ml eluted material for UVC and No-Cl control. If possible,
beads were reused each time after a brief wash in IC lysis buffer. We used fresh
beads in case of extensive clogging after the elution step.
Enzymatic treatment and second purification. Triplicate eluates were pooled in
5-ml Eppendorf LoBind tubes. We added Turbo DNAse buffer and 40 ml Turbo
DNAse; 40 ml superRNAsin; complete protease inhibitor; and incubated in 1.5-ml
protein Lobind Eppendorf tubes at 37 C for 20min. Samples were transferred into
falcon tubes and 3.5ml fresh oligo (dT) dynabeads equilibrated in 12ml IC lysis
buffer were added. After 1 h rotation at RT, beads were collected on a magnet and
the supernatant was kept on 4 C for repeated purification. Beads were washed with
IC lysis buffer for 5min at RT, collected on a magnet and transferred to a 5-ml
protein Lobind tube. Beads were washed twice with wash buffer 1; twice with wash
buffer 2; and twice with wash buffer 3. After transfer to a 1.5-ml LoBind tube,
RNA–protein complexes were incubated in elution buffer at 55 C and 1,100 r.p.m.
for 2min. Beads were collected on a magnet, and the supernatant cleared on the
magnet one more time. The cleared eluate was snap frozen and stored at  80 C.
Beads were resuspended in IC Lysis buffer and added back to the supernatant for
two additional rounds of purification. All three eluates were pooled before
downstream analysis.
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RNA and protein digestion. RNAse buffer (100mM pH 7.4 Tris HCl; 1.5M NaCl;
0.5% NP-40; 5mM DTT) and RNAse A/T1 (200U) were added to the remaining
eluate and incubated for 1 h at 37 C. One per cent of the material was used for
SDS–PAGE and silver staining with the Pierce Silver Stain Kit (Thermo Fisher).
The rest was used in LC-MS/MS.
RNA and DNA analysis. To isolate RNA, 1% of the final pooled eluate was
incubated with proteinase K buffer (50mM pH 7.4 Tris HCl; 750mM NaCl; 1%
SDS; 50mM EDTA; 2.5mM DTT; 25mM CaCl2) and 5 mg proteinase K for 1 h at
50 C. RNA and DNA were isolated with Phenol chloroform. Reverse transcription
was performed with and without RT-enzyme to monitor DNA contamination.
RNA was reverse transcribed using the High-Capacity RNA-to-cDNA Kit
(Invitrogen 4387406). cDNA was quantified on a 7900HT Fast Real-Time PCR
system (Applied Biosystems) using the SYBR Green PCR Master Mix (Invitrogen
4364344).
Primer sequences:
45Sf: 50-TCGCTGCGATCTATTGAAAG-30
45S r: 50-AGGAAGACGAACGGAAGGAC-30
L1.3f: 50-TGAAAACCGGCACAAGACAG-30
L1.3 r: 50-CTGGCCAGAACTTCCAACAC-30
XIST f: 50-CTCCACAATGCTTGCTCTGA-30
XIST r: 50-TAACCCCTGCCTGATAGGTG-30
LC–MS/MS. Samples for the serial RNA interactome capture were reduced in
50mM DTT at 56 C for 1 h and alkylated with a final concentration of 5.5mM
chloroacetamide for 30min. Proteins were precipitated by four excess volumes of
acetone at  20C ON. After two sequential acetone washes, lyophilized pellets
were resuspended in 50mM ammonium bicarbonate and 10% acetonitrile on a
thermo rocker and proteins were digested by 0.75 mg trypsin at 37 C ON. Peptides
were desalted using C18 StageTips (Thermo Scientific, Waltham, MA) and
lyophilized. 10% of each sample was used for direct LC–MS analysis, the rest was
further separated using six pH fractions (pH levels 11, 8, 6, 5, 4 and 3) of strong
anion-exchange chromatography (3M Purification, Meriden, CT), according to
ref. 63. Protein samples from the nuclear and cytosolic fractions were cleaned by
centrifugal filtres (Amicon ultra-3K; Millipore, MA) and subsequently lysed and
reduced in a 6M guanidinium chloride buffer, digested by trypsin and fractionated
by five strong anion-exchange chromatography fractions (SCX, 3M Purification,
Meriden, CT), according to ref. 64. Each strong anion-exchange chromatography
or SCX fraction was dissolved in 5% acetonitrile and 2% formic acid and was
injected for nanoflow reverse-phase liquid chromatography (Dionex Ultimate
3000, Thermo Scientific) coupled online to a Thermo Scientific Q-Exactive Plus
Orbitrap mass spectrometer (nanoLC–MS/MS). Briefly, the LC separation was
performed using a PicoFrit analytical column (75 mm ID 25 cm long, 15 mm Tip
ID (New Objectives, Woburn, MA) packed in-house with 3 mm C18 resin
(Reprosil-AQ Pur, Dr Maisch, Ammerbuch-Entringen, Germany) under 50 C
controlled temperature. Peptides were eluted using a nonlinear gradient from 3.8 to
40% solvent B in solvent A over 180min at 266 nlmin 1 flow rate. Solvent A was
0.1% formic acid and solvent B was 79.9% acetonitrile, 20% H2O, 0.1% formic
acid). Nanoelectrospray was generated by applying 3 kV. A cycle of one full Fourier
transformation scan mass spectrum (300 1,700m/z, resolution of 35,000 at m/z
200) was followed by 12 data-dependent MS/MS scans with a normalised collision
energy of 25 eV. A dynamic exclusion window of 30 s was used to avoid repeated
sequencing of the same peptides. MS data were analysed by MaxQuant (v1.5.0.0)20,
and searched against the ENSEMBL release GRCh37.70 human proteome database,
or UniProtKB with 69,714 entries released in 06/2015, using an FDR of 0.01 for
proteins and peptides with a minimum length of seven amino acids. A maximum
of two missed cleavages in the tryptic digest was allowed. Cysteine
carbamidomethylation was set as a fixed modification, while N-terminal acetylation
and methionine oxidation were set as variable modifications. Ion counts from two
biological replicates were pooled and a threefold ratio of ultraviolet versus non-
crosslinked control was used as cutoff after replacing zero counts in one condition
with a pseudocount of one. LFQ, a generic method for label-free quantification65
within MaxQuant, was used for allocating proteins from nuclear and cytosolic SCX
fractions.
GO and domain analysis. GO annotations, Pfam and Interpro Domain
annotations for the identified proteins were retrieved from the geneontology
website and using ENSEMBL Biomart and the Ensembl Human release 81
(GRCh38.p3). Proteins were grouped for the presence of classic or non-classic
RNA binding domains as in ref. 15. In brief, proteins were first scored for the
presence of at least one classic RBD, the remainder was scored for the presence of
at least one non-classic domain, and the rest were regarded no-RBD proteins.
Enrichments of domains and GO terms were calculated using the DAVID tool.
Corrected P values were obtained by the method of Benjamini–Hochberg.
Disorder and low complexity. For each amino-acid position in a protein a score
for intrinsic disorder was derived using IUPred66. Positions wit a score o0.4 are
regarded disordered, and the proportion of these residues is calculated for each
protein. Complexity was calculated as the Shannon entropy in a window of ±10
amino acids around each amino-acid position in a protein, and the proportion of
positions with an entropy below 3 bit was derived for each protein. Differences in
the distributions of disorder and low complexity regions were tested for
significance using the Kolmogorov–Smirnow test.
Interaction networks. PPI interaction networks were calculated using the
GeneMANIA algorithm. We used the full information provided by the
GeneMANIA database, including 287 co-expression data sets, 3 co-localization
data sets, 7 genetic interaction data sets, 7 pathway collections, 190 data sets with
physical interactions and 42 interaction prediction data sets were used to identify
the 20 next neighbouring proteins of the 22 DDR-related query genes. Only
physical and pathway interactions were used to visualize the network map.
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